Investing.com -- Bristol Myers (NYSE: BMY) Squibb and SystImmune have received Breakthrough Therapy Designation from the U.S.

Investing.com -- India has recommended imposing a three-year import tariff on certain steel products to limit shipments from ...

Investing.com -- U.S. President Donald Trump’s trade advisor Peter Navarro called on India Monday to stop purchasing Russian ...

Investing.com - The U.S. dollar edged higher Monday at the start of a week dominated by moves to try and end the war in ...

Wegovy becomes the first GLP-1 based therapy authorized for MASH, which affects roughly 5% of U.S. adults, according to the ...

Investing.com -- U.S. software stocks may see short-term gains in the current earnings cycle, even as questions over ...

Investing.com -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI) stock surged 32% following positive pre-sNDA meeting responses from the U.S. Food and Drug Administration regarding the potential expansion of ...

Stocks finished Friday lower, and with OPEX now behind us, volatility should begin to expand again. VIX OPEX is on Wednesday, ...

The new rules clarify how projects can qualify under the One Big Beautiful Bill’s safe-harbor provision, which allows assets ...

Trump met Russian counterpart Vladimir Putin in Alaska on Friday, and flagged positive, albeit vague progress in talks.

Investing.com-- Asian currencies broadly traded with caution on Monday, weighed down by reduced expectations for a ...

Investing.com -- Commodity trading advisors (CTAs) remain heavily long U.S. equity futures, with stretched positions in the S&P 500 and Nasdaq 100, according to Bank of America’s Systematic Flows ...